サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：関節痛注射の世界市場－成長、将来展望、競合分析（2022年～2030年）
市場調査レポート
商品コード
1149161

関節痛注射の世界市場－成長、将来展望、競合分析（2022年～2030年）

Joint Pain Injections Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日: | 発行: Acute Market Reports | ページ情報: 英文 120 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
関節痛注射の世界市場－成長、将来展望、競合分析（2022年～2030年）
出版日: 2022年08月01日
発行: Acute Market Reports
ページ情報: 英文 120 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の関節痛注射の市場規模は、2022年から2030年の予測期間中に9.7％のCAGRで成長すると予想されています。腱鞘炎の急増、携帯電話などの電子機器の普及、肥満の増加、関節内補充療法の増加は、関節痛注射市場の成長を牽引しています。

当レポートでは、世界の関節痛注射市場について調査分析し、ビジネス展望、市場力学、市場分析、企業プロファイルなど、体系的な情報を提供しています。

目次

第1章 序文

  • レポートの説明
    • レポートの目的
    • 対象者
    • 主な製品
  • 市場セグメンテーション
  • 調査手法
    • フェーズⅠ－2次調査
    • フェーズⅡ－1次調査
    • フェーズⅢ－専門家による審査
    • 仮定
    • 採用されたアプローチ

第2章 エグゼクティブサマリー

  • 市場スナップショット：世界の関節痛注射市場
  • 世界の関節痛注射市場（100万米ドル）（2021年）：注射別
  • 世界の関節痛注射市場（100万米ドル）（2021年）：関節別
  • 世界の関節痛注射市場（100万米ドル）：地域別
  • COVID-19の影響
  • 魅力的な投資提案（2021年）：地域別
  • 競合分析
    • 主要な関節痛注射市場ベンダーの市場ポジショニング
    • 関節痛注射市場ベンダーが採用する戦略
    • 主要な業界戦略

第3章 関節痛注射市場：ビジネス展望と市場力学

  • イントロダクション
  • 世界の関節痛注射の市場金額（100万米ドル）（2020年～2030年）
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響分析
  • シーソー分析
  • ポーターのファイブフォースモデル
    • サプライヤーの力
    • バイヤーの力
    • 代替品の脅威
    • 新規参入業者の脅威
    • 競争企業間の敵対関係
  • PESTEL分析
    • 政治的
    • 経済的
    • 技術的
    • 法的
    • 社会的

第4章 関節痛注射市場、米ドル（100万）（2020年～2030年）：注射別

  • 市場概要
  • 成長と収益分析：2021年と2030年の比較
  • 市場セグメンテーション
    • ヒアルロン酸注射
    • コルチコステロイド注射
    • その他

第5章 関節痛注射市場、米ドル（100万）（2020年～2030年）：関節別

  • 市場概要
  • 成長と収益分析：2021年と2030年の比較
  • 市場セグメンテーション
    • 股関節
    • 膝・足首
    • 肩・肘
    • 脊椎椎間関節
    • その他

第6章 北米の関節痛注射市場、米ドル（100万）（2020年～2030年）

第7章 英国および欧州連合の関節痛注射市場、米ドル（100万）（2020年～2030年）

第8章 アジア太平洋の関節痛注射市場、米ドル（100万）（2020年～2030年）

第9章 ラテンアメリカの関節痛注射市場、米ドル（100万）（2020年～2030年）

第10章 中東およびアフリカの関節痛注射市場、米ドル（100万）（2020年～2030年）

第11章 企業プロファイル

  • Allergan, Plc.
  • Anika Therapeutics, Inc.
  • Bioventus LLC
  • Chugai Pharmaceutical Co., Ltd.
  • Flexion Therapeutics, Inc.
  • Ferring B.V.
  • Pfizer, Inc.
  • Sanofi S.A.
  • SEIKAGAKU Corporation
  • Zimmer Biomet Holdings, Inc.
図表

List of Tables

  • TABLE 1 Global Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
  • TABLE 2 Global Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
  • TABLE 3 North America Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
  • TABLE 4 North America Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
  • TABLE 5 UK and European Union Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
  • TABLE 6 UK and European Union Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
  • TABLE 7 Asia Pacific Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
  • TABLE 8 Asia Pacific Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
  • TABLE 9 Latin America Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
  • TABLE 10 Latin America Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
  • TABLE 11 Middle East and Africa Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
  • TABLE 12 Middle East and Africa Joint Pain Injections Market By Joint, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Joint Pain Injections Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Joint Pain Injections Market: Quality Assurance
  • FIG. 5 Global Joint Pain Injections Market, By Injection, 2021
  • FIG. 6 Global Joint Pain Injections Market, By Joint, 2021
  • FIG. 7 Global Joint Pain Injections Market, By Geography, 2021
  • FIG. 8 Global Joint Pain Injections Market, By Injection, 2021 Vs 2030, %
  • FIG. 9 Global Joint Pain Injections Market, By Joint, 2021 Vs 2030, %
  • FIG. 10 U.S. Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 11 Canada Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 12 Rest of North America Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 13 UK Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 14 Germany Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 15 Spain Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 16 Italy Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 17 France Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 18 Rest of Europe Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 19 China Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 20 Japan Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 21 India Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 22 Australia Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 23 South Korea Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 24 Rest of Asia Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 25 Brazil Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 26 Mexico Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 27 Rest of Latin America Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 28 GCC Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 29 Africa Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 30 Rest of Middle East and Africa Joint Pain Injections Market (US$ Million), 2020 - 2030
目次
Product Code: 138672-08-22

Industry Outlook

The joint pain injections market is set to exhibiting outstanding growth at a compound annual growth rate (CAGR) of 9.7% during the forecast period from 2022 to 2030. As per the latest research citing brought forward by Global Burden of Disease Study the burden associated with musculoskeletal disorders is approximately 6.8% of DALYs worldwide.

Excellent lubrication and shock absorbing properties similar to synovial fluid has led to the increasing demand for hyaluronic acid injections for joint pains

Hyaluronic acid injection is reigning the injections segment for joint pain injections market. The human joints are similar to gears subjected to constant wear and tear, hyaluronic acid possess excellent lubrication and shock absorbing properties similar to synovial fluid thereby reducing joint stiffness and tenderness. Corticosteroid injections are used as an adjuvant medication in joint pain owing to its anti-inflammatory properties and ability to provide short term relief in joint sprains experienced by athletes and industrial workers.

Significant rise in tenosynovitis and prolonged physical activity drive the knee & ankle joint market growth

Currently knee & ankle joints are dominating the joint segment for joint pain injections market. The major factors associated with its market growth are significant rise in tenosynovitis and prolonged physical activity. Increasing competition among athletes and rampant growth of production and manufacturing segment further bolster the knee & ankle joints market growth. Shoulder & elbow joints are anticipated to register impressive growth in the near future owing to increasing utilization of electronic gadgets such as laptops, personal computer and mobile phones among general population. Rising prevalence of rotator cuff injury further consolidate the shoulder & elbow joints market growth.

Rising prevalence of obesity and high acceptance of viscosupplementation drive the market growth in North America

North America with a share of 34% is leading the regional segment for joint pain injections market. The chief attributes responsible for its dominance are rising prevalence of obesity and high acceptance of viscosupplementation. Domicile of key players such as Sanofi S.A., Allergan, Plc., Pfizer, Inc. etc. provide necessary impetus to the joint pain injections market growth in North America region. Europe is in the second position with a share of 28% owing to the rising prevalence of osteoarthritis in geriatric population. Affordable reimbursement scenario associated with joint pain injections propel the market growth in European region. Asia Pacific holds 20% market share and will grow at a faster pace during the forecast period on account of significant rise in musculoskeletal disorders and increasing cases of accidents and physical trauma.

Pharmaceutical companies pioneering in the joint pain injections market are: Allergan, Plc., Anika Therapeutics, Inc., Bioventus LLC., Chugai Pharmaceutical Co., Ltd., Flexion Therapeutics, Inc., Ferring B.V., Pfizer, Inc., Sanofi S.A., SEIKAGAKU Corporation and Zimmer Biomet Holdings, Inc.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Joint Pain Injections market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Joint Pain Injections market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Injection

  • Hyaluronic Acid Injections
  • Corticosteroid Injections
  • Others

Joint

  • Hip Joint
  • Knee & Ankle
  • Shoulder & Elbow
  • Facet Joints of the Spine
  • Others

Region Segment (2020-2030; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

  • Pre COVID-19 situation
  • Post COVID-19 situation

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Joint Pain Injections market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Joint Pain Injections market?
  • Which is the largest regional market for Joint Pain Injections market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Joint Pain Injections market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Joint Pain Injections market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Joint Pain Injections Market
  • 2.2. Global Joint Pain Injections Market, By Injection, 2021 (US$ Million)
  • 2.3. Global Joint Pain Injections Market, By Joint, 2021 (US$ Million)
  • 2.4. Global Joint Pain Injections Market, By Geography, 2021 (US$ Million)
  • 2.5. Impact of Covid 19
  • 2.6. Attractive Investment Proposition by Geography, 2021
  • 2.7. Competitive Analysis
    • 2.7.1. Market Positioning of Key Joint Pain Injections Market Vendors
    • 2.7.2. Strategies Adopted by Joint Pain Injections Market Vendors
    • 2.7.3. Key Industry Strategies

3. Joint Pain Injections Market: Business Outlook & Market Dynamics

  • 3.1. Introduction
  • 3.2. Global Joint Pain Injections Market Value, 2020 - 2030, (US$ Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers
    • 3.3.2. Market Restraints
    • 3.3.3. Key Challenges
    • 3.3.4. Key Opportunities
  • 3.4. Impact Analysis of Drivers and Restraints
  • 3.5. See-Saw Analysis
  • 3.6. Porter's Five Force Model
    • 3.6.1. Supplier Power
    • 3.6.2. Buyer Power
    • 3.6.3. Threat Of Substitutes
    • 3.6.4. Threat Of New Entrants
    • 3.6.5. Competitive Rivalry
  • 3.7. PESTEL Analysis
    • 3.7.1. Political Landscape
    • 3.7.2. Economic Landscape
    • 3.7.3. Technology Landscape
    • 3.7.4. Legal Landscape
    • 3.7.5. Social Landscape

4. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)

  • 4.1. Market Overview
  • 4.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 4.3. Market Segmentation
    • 4.3.1. Hyaluronic Acid Injections
    • 4.3.2. Corticosteroid Injections
    • 4.3.3. Others

5. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Hip Joint
    • 5.3.2. Knee & Ankle
    • 5.3.3. Shoulder & Elbow
    • 5.3.4. Facet Joints of the Spine
    • 5.3.5. Others

6. North America Joint Pain Injections Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
  • 6.3. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
  • 6.4.Joint Pain Injections Market: By Region, 2020-2030, USD (Million)
    • 6.4.1.North America
      • 6.4.1.1. U.S.
      • 6.4.1.2. Canada
      • 6.4.1.3. Rest of North America

7. UK and European Union Joint Pain Injections Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
  • 7.3. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
  • 7.4.Joint Pain Injections Market: By Region, 2020-2030, USD (Million)
    • 7.4.1.UK and European Union
      • 7.4.1.1. UK
      • 7.4.1.2. Germany
      • 7.4.1.3. Spain
      • 7.4.1.4. Italy
      • 7.4.1.5. France
      • 7.4.1.6. Rest of Europe

8. Asia Pacific Joint Pain Injections Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
  • 8.3. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
  • 8.4.Joint Pain Injections Market: By Region, 2020-2030, USD (Million)
    • 8.4.1.Asia Pacific
      • 8.4.1.1. China
      • 8.4.1.2. Japan
      • 8.4.1.3. India
      • 8.4.1.4. Australia
      • 8.4.1.5. South Korea
      • 8.4.1.6. Rest of Asia Pacific

9. Latin America Joint Pain Injections Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
  • 9.3. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
  • 9.4.Joint Pain Injections Market: By Region, 2020-2030, USD (Million)
    • 9.4.1.Latin America
      • 9.4.1.1. Brazil
      • 9.4.1.2. Mexico
      • 9.4.1.3. Rest of Latin America

10. Middle East and Africa Joint Pain Injections Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
  • 10.3. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
  • 10.4.Joint Pain Injections Market: By Region, 2020-2030, USD (Million)
    • 10.4.1.Middle East and Africa
      • 10.4.1.1. GCC
      • 10.4.1.2. Africa
      • 10.4.1.3. Rest of Middle East and Africa

11. Company Profile

  • 11.1. Allergan, Plc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Portfolio
    • 11.1.4. Strategic Initiatives
  • 11.2. Anika Therapeutics, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Initiatives
  • 11.3. Bioventus LLC
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Portfolio
    • 11.3.4. Strategic Initiatives
  • 11.4. Chugai Pharmaceutical Co., Ltd.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Portfolio
    • 11.4.4. Strategic Initiatives
  • 11.5. Flexion Therapeutics, Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Portfolio
    • 11.5.4. Strategic Initiatives
  • 11.6. Ferring B.V.
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Portfolio
    • 11.6.4. Strategic Initiatives
  • 11.7. Pfizer, Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Portfolio
    • 11.7.4. Strategic Initiatives
  • 11.8. Sanofi S.A.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Portfolio
    • 11.8.4. Strategic Initiatives
  • 11.9. SEIKAGAKU Corporation
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Portfolio
    • 11.9.4. Strategic Initiatives
  • 11.10. Zimmer Biomet Holdings, Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Portfolio
    • 11.10.4. Strategic Initiatives